Who owns CORCEPT THERAPEUTICS INC (CORT)? Elite investor 13F holders

4 tracked elite investors reported holding CORCEPT THERAPEUTICS INC as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Gotham Asset Management, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. The company offers Korlym, an oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Renaissance Technologies LLCCORCEPT THERAPEUTICS INCSHARE2026-06-302026-08-13 00:00:00457498555.00 USD5261628.000000SharesreduceOriginal filing
D.E. ShawCORCEPT THERAPEUTICS INCSHARE2026-06-302026-08-14 00:00:0076776937.00 USD883001.000000SharesreduceOriginal filing
Gotham Asset ManagementCORCEPT THERAPEUTICS INCSHARE2026-06-302026-08-14 00:00:005232738.00 USD60181.000000SharesaddOriginal filing
Bridgewater AssociatesCORCEPT THERAPEUTICS INCSHARE2026-06-302026-08-14 00:00:005008494.00 USD57602.000000SharesaddOriginal filing
Tudor InvestmentCORCEPT THERAPEUTICS INCSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown